Show simple item record

Clinical role of lung clearance index in the assessment of cystic fibrosis lung disease

dc.contributor.advisorCunningham, Steve
dc.contributor.authorArmstrong, David K.
dc.date.accessioned2023-02-01T17:39:23Z
dc.date.available2023-02-01T17:39:23Z
dc.date.issued2019-05-31
dc.identifier.urihttps://hdl.handle.net/1842/39793
dc.identifier.urihttp://dx.doi.org/10.7488/era/3041
dc.description.abstract[No Deposit Agreement]en
dc.language.isoenen
dc.publisherThe University of Edinburghen
dc.relation.hasversionAlton E, Armstrong DK, Ashby D, et al. Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial. Lancet Respir Med 2015;3(9):684-91.en
dc.relation.hasversionArmstrong DK et al. Gene therapy in cystic fibrosis. Arch Dis Child 2014;99(5):465-8.en
dc.subjectlung clearance indexen
dc.subjectcystic fibrosisen
dc.subjectlung diseaseen
dc.subjectcystic fibrosis lung diseaseen
dc.subjectMultiple Breath Washouten
dc.subjectearly small airways diseaseen
dc.subjectSF6MBW derived LCIen
dc.subjectCF lung diseaseen
dc.titleClinical role of lung clearance index in the assessment of cystic fibrosis lung diseaseen
dc.title.alternativeThe clinical role of lung clearance index in the assessment of cystic fibrosis lung diseaseen
dc.typeThesis or Dissertationen
dc.type.qualificationlevelDoctoralen
dc.type.qualificationnameMD Doctor of Medicineen


Files in this item

Name:
ArmstrongDK_2019.pdf
Size:
5.278Mb
Format:
PDF

This item appears in the following Collection(s)

  • Edinburgh Medical School thesis and dissertation collection

    • Show simple item record